ClinicalTrials.Veeva

Menu

Glu298Asp Polymorphism and Blood Pressure

University of Reading logo

University of Reading

Status

Completed

Conditions

Hypertension

Treatments

Dietary Supplement: Bread

Study type

Interventional

Funder types

Other

Identifiers

NCT02037308
University of Reading (Other Identifier)
10/18G

Details and patient eligibility

About

The Glu298Asp polymorphism has been linked to increased risk of cardiovascular events, proposed to be due to reduced nitric oxide production by eNOS reported in some but not all studies. We hypothesise that beetroot-enriched bread interacts with the Glu298Asp polymorphism of the eNOS gene to lower blood pressure and increase plasma nitrate/nitrite, particularly in carriers of the T allele, which have been associated with lower eNOS activity and increased risk of hypertension.

Enrollment

14 patients

Sex

Male

Ages

18 to 64 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male
  • A signed consent form
  • Age 18-64 years
  • Body mass index - 18.5-30 kg/m2
  • Non-smoking, healthy individuals
  • Normal blood pressure at screening (< 150/90)

Exclusion criteria

  • Subjects with anaemia
  • Sufferers of chronic illnesses
  • Individuals with food allergies
  • People with diabetes
  • People with coeliac disease
  • Women
  • Vegetarians

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

14 participants in 2 patient groups, including a placebo group

Control white bread
Placebo Comparator group
Treatment:
Dietary Supplement: Bread
Beetroot bread
Experimental group
Treatment:
Dietary Supplement: Bread

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems